Loading....
WEBINAR DESCRIPTION
In this webinar, Drs. Fadi Haddad and Jayastu Senapati will discuss the diagnosis secondary AML from MDS, treatment options available to patients and symptom management. Questions can be submitted in advance to help@aamds.org.
Thank you to our 2025 Sponsors.
Diamond Level
Silver Level
Bronze Level
WEBINAR FACULTY
Fadi Haddad, MD, is an Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. Dr. Haddad’s research focuses on developing novel strategies for hematologic malignancies, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). He has served as principal investigator or co-investigator for numerous clinical trials, lectured nationally and internationally, and published extensively on clinical aspects of CML, ALL, and acute myeloid leukemia.
Jayastu Senapati, MD is an Assistant Professor in the Dept of Leukemia at the University of Texas MD Anderson Cancer Center, Houston Texas. Dr. Senapati treats patients with acute and chronic leukemias and focuses on management of critical acute leukemia patients. He believes in patient centric leukemia care, that is driven by the latest research and evidence-based medicine. His research focus is primarily on acute myeloid leukemia and acute lymphoblastic leukemia, and he has been involved in several clinical trials and research projects.
Thank you for registering for this webinar.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone.
If you do not receive the link, please check your Spam/Junk folders.
If you have not received a registration confirmation, please email clark@aamds.org
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.